GRVE - Groove Botanicals secures exclusive rights for CannSol's anti-viral plant extract distribution in the U.S.

Groove Botanicals (GRVE) enters into a licensing agreement with CannSol Distribution AG to receive exclusive distribution rights for CannSol’s anti-viral Curcuma/Frankincense plant extract in the U.S.The agreement also includes the rights for two other unique products, Coenzym Q10 which plays an important role in cell aging and in the energy balance of the cells for adults over the age of 35 and Mono-Plant Extract Curcuma which has been used for treatment of type two diabetes and to increase the metabolism of fat metabolism as well as for detoxification. CannSol Holding AG is a licensor of Swiss-made next generation natural plant extracts and food supplements that are both 100% water soluble and 100% vegan."We are delighted to sign this exclusive licensing agreement with CannSol and look forward to commencing sales of their Curcuma/Frankincense Extract and the other unique plant extracts in the United States in 2021," says Groove president and CEO Kent Rodriguez. He adds "Recent scientific studies have indicated

For further details see:

Groove Botanicals secures exclusive rights for CannSol’s anti-viral plant extract distribution in the U.S.